These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11031723)

  • 1. Therapy of patients with IgA-nephropathy: a critical appraisal.
    Floege J; Mertens P
    Kidney Blood Press Res; 2000; 23(3-5):207-9. PubMed ID: 11031723
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of IgA nephropathy: status at the end of the millenium.
    Glassock RJ
    J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA nephropathy treatment 25 years on: can we halt progression? The evidence base.
    Ballardie FW
    Nephrol Dial Transplant; 2004 May; 19(5):1041-6. PubMed ID: 15102965
    [No Abstract]   [Full Text] [Related]  

  • 4. [Update in primary glomerular diseases--mainly in IgA nephropathy].
    Kawamura T
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):514-23. PubMed ID: 12476587
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin A nephropathy: fish oils and beyond.
    Feehally J
    Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):442-6. PubMed ID: 8937814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IgA nephropathy--pathogenesis, pathophysiology, and therapy].
    Narita I; Goto S; Kondo D; Sakatsume M; Gejyo F
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():397-402. PubMed ID: 16523921
    [No Abstract]   [Full Text] [Related]  

  • 7. IgA nephropathy.
    Wardle EN
    N Engl J Med; 2003 Jan; 348(1):79-81; author reply 79-81. PubMed ID: 12510692
    [No Abstract]   [Full Text] [Related]  

  • 8. New therapeutic approaches in primary IgA nephropathy.
    Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Bolasco P; Fogazzi G; Altieri P; Ponticelli C
    Adv Nephrol Necker Hosp; 1999; 29():73-91. PubMed ID: 10561738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of IgA nephropathies: a critical viewpoint].
    Mertens PR; Floege J
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1010. PubMed ID: 11004914
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating IgA nephropathy: quid novi?
    Hartono C; Muthukumar T
    Discov Med; 2014 Mar; 17(93):131-8. PubMed ID: 24641955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy: to treat or not to treat?
    Scheinman JI; Trachtman H; Lin CY; Langman CB; Chan JC
    Nephron; 1997; 75(3):251-8. PubMed ID: 9069444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of IgA Nephropathy: Evolution Over Half a Century.
    Barratt J; Tang SCW
    Semin Nephrol; 2018 Sep; 38(5):531-540. PubMed ID: 30177025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary IgA nephropathy.
    Alexopoulos E
    Kidney Int; 2004 Jan; 65(1):341-55. PubMed ID: 14675076
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evidence of therapy of IgA nephropathy].
    Gan WH; Zhang AQ; Ding GX; Gong J
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):101-3. PubMed ID: 17448301
    [No Abstract]   [Full Text] [Related]  

  • 15. Fish oil for IgA nephropathy?
    van Ypersele de Strihou C
    N Engl J Med; 1994 Nov; 331(18):1227-9. PubMed ID: 7935665
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmapheresis in the treatment of IgA nephropathy.
    Macanović M; Golemac S; Macanović K; Hadzijahić H; Verbić D
    Przegl Lek; 1985; 42(3):355-7. PubMed ID: 4048517
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on immunosuppressive therapy in human and experimental glomerulonephritis.
    Jacquot C; Baran D; Vendeville B; Pelletier L; Druet P
    Adv Nephrol Necker Hosp; 1988; 17():77-99. PubMed ID: 3124553
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment tentatives in IgA nephropathy.
    Clarkson AR; Woodroffe AJ
    Semin Nephrol; 1987 Dec; 7(4):393-8. PubMed ID: 3127870
    [No Abstract]   [Full Text] [Related]  

  • 19. IgA nephropathy: lessons from an animal model, the ddY mouse.
    Tomino Y
    J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgA-nephropathy: the most common type of glomerulonephritis].
    Mertens PR; Floege J
    Dtsch Med Wochenschr; 2003 May; 128(22):1242-6. PubMed ID: 12772083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.